000			01574 a2200409 4500
005			20250517152734.0
264		0	_c20170607
008			201706s 0 0 eng d
022			_a1365-229X
024	7		_a10.1016/j.crad.2017.04.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aAlessandrino, F
245	0	0	_aImaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors. _h[electronic resource]
260			_bClinical radiology _cJul 2017
300			_a521-533 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntibodies, Monoclonal, Humanized _xadverse effects
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aCancer Care Facilities
650	0	4	_aChemical and Drug Induced Liver Injury _xdiagnostic imaging
650	0	4	_aDecision Trees
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aIpilimumab
650	0	4	_aMolecular Targeted Therapy _xadverse effects
650	0	4	_aNivolumab
650	0	4	_aTertiary Care Centers
700	1		_aTirumani, S H
700	1		_aKrajewski, K M
700	1		_aShinagare, A B
700	1		_aJagannathan, J P
700	1		_aRamaiya, N H
700	1		_aDi Salvo, D N
773	0		_tClinical radiology _gvol. 72 _gno. 7 _gp. 521-533
856	4	0	_uhttps://doi.org/10.1016/j.crad.2017.04.003 _zAvailable from publisher's website
999			_c27145922 _d27145922